Fitzpatrick M.E., Kunisaki K.M., Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy // AIDS. 2018. No. 32 (3). Р. 277–292. doi: 10.1097/QAD.0000000000001712..
DOI: 10.1097/QAD.0000000000001712

Шахгильдян В.И., Ядрихинская М.С., Сафонова А.П., Домонова Э.А., Шипулина О.Ю., Альварес-Фигероа М.В., Долгова Е.А., Тишкевич О.А. Структура вторичных заболеваний и современные походы к их лабораторной диагностике у больных ВИЧ-инфекцией // Эпидемиология и инфекционные болезни. 2015. No. 1. С.24–30.

Ханин А.Л., Шабина О.П., Викторова И.Б. Болезни органов дыхания в промышленном регионе Сибири: анализ заболеваемости на примере Кемеровской области // Вестник современной клинической медицины. 2019. Т. 12. Вып. 3. С. 47–53. doi: 10.20969/VSKM.2019.12(3).47–53.
DOI: 10.20969/VSKM.2019.12(3).47–53

Maitre T., Cottenet J., Beltramo G., Georges M., Blot M., Piroth L., Bonniaud P., Quantin C. Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database // Eur. Respir. J. 2018. No. 52 (3). рii: 800359. doi: 10.1183/13993003.00359-2018..
DOI: 10.1183/13993003.00359-2018

Боровицкий В.С., Овчинникова Е.В., Халявина А.А., Тюлькин С.А., Тюлькин О.П. Особенности диагностики хронической обструктивной болезни легких у лиц, инфицированных вирусом иммунодефицита человека, отбывающих наказание в учреждениях Федеральной службы исполнения наказаний России в Кировской области // Пульмонология. 2016. № 26 (6). С. 715–718. https://doi.org/10.18093/0869-01892016-26-6-715-718.
DOI: 10.18093/0869-01892016-26-6-715-718

Samji H., Cescon A., Hogg R.S., Modur S.P., Althoff K.N, Buchacz K., Burchell A.N., Cohen M., Gebo K.A, Gill M.J., Justice A., Kirk G., Klein M.B., Korthuis P.T., Martin J., Napravnik S., Rourke S.B., Sterling T.R., Silverberg M.J., Deeks S., Jacobson L.P., Bosch R.J., Kitahata M.M., Goedert J.J., Moore R., Gange S.J; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada // PLoS One. 2013. Dec. 18; Vol. 8 (12): e81355. doi: 10.1371/journal.pone.0081355. PMID: 24367482; PMCID: PMC3867319..
DOI: 10.1371/journal.pone.0081355

Makinson A., Hayot M., Eymard-Duvernay S., Quesnoy M., Raffi F., Thirard L., Bonnet F., Tattevin P., Abgrall S., Quantin X., Léna H., Bommart S., Reynes J., Le Moing V.; ANRS EP48 HIV CHEST Study Team. High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers // Eur. Respir J. 2015. No. 45(3). Р. 828–831. doi: 10.1183/09031936.00154914. Epub 2014 Oct 16..
DOI: 10.1183/09031936.00154914. Epub 2014 Oct 16

Raynaud C., Roche N., Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects // Respir Res. 2011. No 12 (1). Р. 117. doi: 10.1186/1465–9921–12–117..
DOI: 10.1186/1465–9921–12–117

Madeddu G., Fois A.G., Calia G.M., Babudieri S., Soddu V., Becciu F., Fiori M.L., Spada V., Lovigu C., Mannazzu M., Caddeo A., Piras B., Pirina P., Mura M.S. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? // Infection. 2013. No. 41 (2). Р. 347–353. doi: 10.1007/s15010-012-0330-x..
DOI: 10.1007/s15010-012-0330-x

Bigna J.J., Kenne A.M., Asangbeh S.L. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis // Lancet Glob. Health. 2018. No. 6 (2). e193-e202. doi: 10.1016/S2214-109X(17)30451-5..
DOI: 10.1016/S2214-109X(17)30451-5

Drummond M.B., Kirk G.D. HIV-associated obstructive lung diseases: insights and implications for the clinician // Lancet Respir. Med. 2014. No. 2 (7). Р. 583–592. doi: 10.1016/S2213-2600(14)70017..
DOI: 10.1016/S2213-2600(14)70017

Crothers K., Huang L., Goulet J.L., Goetz M.B., Brown S.T., Rodriguez-Barradas M.C., Oursler K.K., Rimland D., Gibert C.L., Butt A.A., Justice A.C. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era // Am. J. Respir. Crit Care Med. 2011. No 183 (3). Р. 388–395.

Kuhlman J.E., Knowles M.C., Fishman E.K., Siegelman S.S. Premature bullous pulmonary damage in AIDS: CT diagnosis // Radiology. 1989. No. 173 (1). Р. 23–26.

Diaz P.T., King M.A., Pacht E.R., Wewers M.D., Gadek J.E., Nagaraja H.N., Drake J., Clanton T.L. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers // Ann. Intern. Med. 2000. No. 132. Р. 369–372.

Petrache I., Diab K., Knox K.S. Twigg H.L. 3rd, Stephens R.S., Flores S., Tuder R.M. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism // Thorax. 2008. No. 63. Р. 463–469. doi: 10.1136/thx.2007.079111..
DOI: 10.1136/thx.2007.079111

Ronit A., Kristensen T., Hoseth V.S., Abou-Kassem D., Kühl J.T., Benfield T., Gerstoft J., Afzal S., Nordestgaard B.G., Lundgren J.D., Vestbo J., Kofoed K.F., Nielsen S.D. Copenhagen Comorbidity in HIV Infection (COCOMO) study group. Computed tomography quantification of emphysema in people living with HIV and uninfected controls // Eur. Respir. J. 2018. No. 52 (1). pii: 1800296. doi: 10.1183/13993003.00296-2018. Print 2018 Jul..
DOI: 10.1183/13993003.00296-2018. Print 2018 Jul

Triplette M., Justice A., Attia E.F., Tate J., Brown S.T., Goetz M.B., Kim J.W., Rodriguez-Barradas M.C., Hoo G.W.S., Wongtrakool C., Akgün K., Crothers K. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV // AIDS. 2018. No. 32 (4). Р. 487–493. doi: 10.1097/QAD.0000000000001701..
DOI: 10.1097/QAD.0000000000001701

Rosen M.J., Lou Y., Kvale P.A., Rao A.V., Jordan M.C., Miller A., Glassroth J., Reichman L.B, Wallace J.M., Hopewell P.C. Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group // Am. J. Respir. Crit Care Med. 1995. No. 152 (2). Р. 738–745.

Guaraldi G., Besutti G., Scaglioni R., Santoro A., Zona S., Guido L., Marchioni A., Orlando G., Carli F., Beghe B., Fabbri L., Leipsic J., Sin D.D. Man S.F. The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy // PLoS ONE. 2014. No. 9 (10). e109027. doi: 10.1371/journal.pone.0109027..
DOI: 10.1371/journal.pone.0109027

Tashkin D.P. Heroin Smoking and COPD // Chest. 2019. No. 2. Vol. 155. Р. 247–248.

Walker P.P., Thwaite E., Amin S., Curtis J.M., Calverley P.M.A. The association between heroin inhalation and early onset emphysema // Chest. 2015. No. 148. Р. 1156–1163.

Raynaud C., Roche N., Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects // Respir. Res. 2011. No. 12. Р. 117. doi: 10.1186/1465-9921-12-117..
DOI: 10.1186/1465-9921-12-117

Besutti G., Santoro A., Scaglioni R. Neri S., Zona S., Malagoli A., Orlando G., Beghè B., Ligabue G., Torricelli P., Manfredini M., Pellacani G., Fabbri L.M., Guaraldi G. Significant chronic airway abnormalities in never‐smoking HIV‐infected patients // HIV Med. 2019. No. 20 (10). Р. 657–667. doi: 10.1111/hiv.12785..
DOI: 10.1111/hiv.12785

Deeks S.G. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy // Top HIV Med. 2009. No 17 (4). Р. 118–123.

Lalloo U.G., Pillay S., Mngqibisa R. Abdool‐Gaffar S., Ambaram A. HIV and COPD: a conspiracy of risk factors. // Respirology. 2016. No. 21 (7). Р. 1166–1172. doi: 10.1111/resp.12806..
DOI: 10.1111/resp.12806

Collini P., Morris A. Maintaining lung health with longstanding HIV // Curr. Opin. Infect. Dis. 2016. No. 29 (1). Р. 31–38. doi: 10.1097/QCO.0000000000000221..
DOI: 10.1097/QCO.0000000000000221

Singhvi D., Bon J., Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis // Curr. HIV/AIDS. Rep. 2019. No 16 (4). Р. 359–369. doi: 10.1007/s11904-019-00456-3..
DOI: 10.1007/s11904-019-00456-3

Morris A., George M.P., Crothers K., Huang L., Lucht L., Kessinger C., Kleerup E.C. Lung HIV Study. HIV and chronic obstructive pulmonary disease: is it worse and why? // Proc. Am. Thorac. Soc. 2011. No. 8 (3). Р. 320–325. doi: 10.1513/pats.201006-045WR..
DOI: 10.1513/pats.201006-045WR

Drummond M.B, Kirk G.D. HIV-associated obstructive lung diseases: insights and implications for the clinician // Lancet Respir Med. 2014. No. 2 (7). Р. 583–592. doi: 10.1016/S2213-2600(14)70017-7..
DOI: 10.1016/S2213-2600(14)70017-7

Gingo M.R., Morris A., Crothers K. Human immunodeficiency virus-associated obstructive lung diseases // Clin. Chest Med. 2013. No. 34 (2). Р. 273–282. doi: 10.1016/j.ccm.2013.02.002..
DOI: 10.1016/j.ccm.2013.02.002

Benito N., Rañó A., Moreno A., González J., Luna M., Agustí C., Danés C., Pumarola T., Miró J.M., Torres A., Gatell J.M. Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy in Spain // J. Acquir Immune Defic Syndr. 2001. No. 27. Р. 35–43.

Attia E.F., McGinnis K.A., Feemster L.C., Akgün K.M., Butt A.A., Graber C.J., Fine M.J., Goetz M.B., Rodriguez-Barradas M.C., Pisani M.A., Tindle H.A., Brown S.T., Soo Hoo G.W., Rimland D., Gibert C.L., Huang L., Freiberg M.S., Hough C.L., Crothers K. Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans // J. Acquir Immune Defic Syndr. 2015. No 70 (3). Р. 280–288. doi: 10.1097/QAI.0000000000000751..
DOI: 10.1097/QAI.0000000000000751

Morris A., Sciurba F.C., Lebedeva I.P., Githaiga A., Elliott W.M., Hogg J.C., Huang L., Norris K.A. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization // Am. J. Respir. Crit Care Med. 2004. No. 170 (4). Р. 408–413.

Gordin F.M., Roediger M.P., Girard P.M., Lundgren J.D., Miro J.M., Palfreeman A., Rodriguez-Barradas M.C., Wolff M.J., Easterbrook P.J., Clezy K., Slater L.N. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption // Am. J. Respir. Crit. Care Med. 2008. No. 178 (6). Р. 630–636.

Kohli R., Lo Y., Homel P., Flanigan T.P., Gardner L.I., Howard A.A., Rompalo A.M., Moskaleva G., Schuman P., Schoenbaum EE; HER Study Group. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study // Clin. Infect. Dis. 2006. No. 43. Р. 90–98.

Miquez-Burbano M.J., Burbano X., Ashkin D., Pitchenik A., Allan R., Pineda L., Rodriguez N., Shor-Posner G. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antirretroviral therapy // Addict Biol. 2003. No. 8. Р. 39–43.

Singhvi D., Bon J., Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis // Curr. HIV/AIDS Rep. 2019. No. 16 (4). Р. 359–369. doi: 10.1007/s11904-019-00456-3..
DOI: 10.1007/s11904-019-00456-3

De Miguel-Díez J., López-de-Andrés A., Jiménez-García R., Puente-Maestu L., Jiménez-Trujillo I., Hernández-Barrera V., Resino S., ÁlvaroMeca A. Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997–2012) // PLoS One. 2016. No 11 (11). e0166421. doi: 10.1371/journal.pone.0166421..
DOI: 10.1371/journal.pone.0166421

Depp T.B., McGinnis K.A., Kraemer K., Akgün K.M., Edelman E.J., Fiellin D.A., Butt A.A., Crystal S., Gordon A.J., Freiberg M., Gibert C.L., Rimland D., Bryant K.J., Crothers K. Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients // AIDS. 2016. No. 30 (3). Р. 455–463. doi: 10.1097/QAD.0000000000000940..
DOI: 10.1097/QAD.0000000000000940

Lambert A.A., Kirk G.D., Astemborski J., Mehta S.H., Wise R.A., Drummond M.B. HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD // J. Acquir. Immune Defic. Syndr. 2015. No 69 (1). Р. 68–74. doi: 10.1097/QAI.0000000000000552.
DOI: 10.1097/QAI.0000000000000552

Drummond M.B., Dasenbrook E.C., Pitz M.W., Murphy D.J., Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis // JAMA. 2008. No 300 (20). Р. 2407–2416

Lee C.H., Kim K., Hyun M.K., Jang E.J., Lee N.R., Yim J.J. Use of inhaled corticosteroids and the risk of tuberculosis // Thorax. 2013. No. 68 (12). Р. 1105–1113.

Brassard P., Suissa S., Kezouh A., Ernst P. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases // Am. J. Respir. Crit Care Med. 2011. No 183. Р. 675–678.

Bernecker C., West T.B., Mansmann G., Scherbaum W.A., Willenberg H.S. Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature // Exp. Clin. Endocrinol. Diabetes. 2012. No. 120. Р. 125–127.

Kaviani N., Bukberg P., Manessis A, Yen V., Young I. Iatrogenic osteoporosis, bilateral HIP osteonecrosis, and secondary adrenal suppression in an HIV-infected man receiving inhaled corticosteroids and ritonavir-boosted highly active antiretroviral therapy // Endocr. Pract. 2011. No. 17. Р. 74–78.

Blondin M.C, Beauregard H., Serri O. Iatrogenic Cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review // Еndocr. Pract. 2013. No. 19. e138–141.

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 1/10/2020.http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 1/10/2020.http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf